The CNS Tumor and Sarcoma Methylation Classifiers are now provided through our company Epignostix, but their underlying technology and functionality remain the same as those previously offered via the academic MNP website (molecular neuropathology.org). They continue to be free of charge and intended for research use only. As a company, we can now ensure more stable access to the classifiers and offer improved user support to enhance your experience.